We are live on ! Find out more
ECP

Elk Creek Partners Portfolio holdings

AUM $582M
1-Year Est. Return 10.23%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
AUM
$1.34B
AUM Growth
-$48.8M
Cap. Flow
-$46.2M
Cap. Flow %
-3.45%
Top 10 Hldgs %
22.05%
Holding
140
New
8
Increased
36
Reduced
80
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 25.27%
2 Technology 15.92%
3 Industrials 15.31%
4 Communication Services 11.67%
5 Consumer Discretionary 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALO icon
26
Halozyme
HALO
$9.79B
$13.9M 1.04%
809,955
+21,254
+3% +$343K
TVTY
27
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$13.9M 1.04%
846,183
+136,199
+19% +$2.63M
MDCO
28
DELISTED
Medicines Co
MDCO
$13.7M 1.02%
374,399
-385,826
-51% -$12.6M
NNBR icon
29
NN Inc
NNBR
$255M
$13.6M 1.02%
1,397,945
+267,527
+24% +$2.32M
LMNX
30
DELISTED
Luminex Corp
LMNX
$13.5M 1.01%
652,505
+343,733
+111% +$7.55M
ZWS icon
31
Zurn Elkay Water Solutions
ZWS
$8.38B
$13.5M 1.01%
924,237
+25,686
+3% +$346K
EFII
32
DELISTED
Electronics for Imaging
EFII
$13.2M 0.99%
357,190
-472,501
-57% -$16.9M
PTCT icon
33
PTC Therapeutics
PTCT
$5.64B
$13.1M 0.98%
290,150
-177,387
-38% -$7M
TDOC icon
34
Teladoc Health
TDOC
$1.22B
$12.9M 0.96%
193,687
+28,671
+17% +$1.67M
ACHC icon
35
Acadia Healthcare
ACHC
$2.76B
$12.7M 0.95%
364,197
+63,403
+21% +$2.05M
EVOP
36
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$12.5M 0.94%
397,503
+60,804
+18% +$1.77M
MAXR
37
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$12.5M 0.94%
1,600,405
-57,045
-3% -$354K
GDOT icon
38
Green Dot
GDOT
$743M
$12.5M 0.93%
255,314
+27,950
+12% +$1.52M
HRTX icon
39
Heron Therapeutics
HRTX
$93.9M
$12.4M 0.93%
+668,240
New +$13.3M
INFN
40
DELISTED
Infinera Corporation Common Stock
INFN
$12.1M 0.9%
4,153,218
+561,196
+16% +$2.11M
CARB
41
DELISTED
Carbonite Inc
CARB
$11.9M 0.89%
457,359
+20,038
+5% +$489K
KNSL icon
42
Kinsale Capital Group
KNSL
$8.12B
$11.9M 0.89%
130,084
-33,372
-20% -$2.67M
SGRY icon
43
Surgery Partners
SGRY
$2.01B
$11.8M 0.88%
1,454,427
+81,164
+6% +$809K
WWE
44
DELISTED
World Wrestling Entertainment
WWE
$11.5M 0.86%
159,101
-5,651
-3% -$463K
REVG
45
DELISTED
REV Group
REVG
$11.5M 0.86%
796,070
-1,730
-0.2% -$21.1K
EPAC icon
46
Enerpac Tool Group
EPAC
$1.83B
$11.4M 0.85%
458,061
-16,476
-3% -$404K
PTLA
47
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$11.3M 0.85%
417,589
+15,322
+4% +$480K
VCRA
48
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$11.1M 0.83%
347,159
-12,342
-3% -$394K
EYE icon
49
National Vision
EYE
$1.77B
$11M 0.83%
359,512
-12,896
-3% -$370K
CASA
50
DELISTED
Casa Systems, Inc. Common Stock
CASA
$11M 0.82%
1,716,869
-61,651
-3% -$451K

Similar funds

Elk Creek Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Elk Creek Partners held 140 positions worth $1.34B, down 3.5% from $1.39B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Elk Creek Partners withdrew a net $46.2M in Q2 2019, closing 16 positions and reducing 80 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $17.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, Elk Creek Partners opened a new position in Heron Therapeutics worth $12.4M.

  • Elk Creek Partners's largest Q2 2019 buy was Heron Therapeutics: 668,240 shares worth $12.4M.
  • Elk Creek Partners added most to Clovis Oncology, Inc. in Q2 2019, an estimated $9.49M increase.
  • Elk Creek Partners's biggest Q2 2019 reduction was Electronics for Imaging, cutting an estimated $16.9M.
  • Elk Creek Partners fully exited R1 RCM Inc. Common Stock in Q2 2019, selling an estimated $17.2M.
  • Elk Creek Partners's ten largest holdings make up 22% of its $1.34B portfolio in Q2 2019.
  • Elk Creek Partners opened 8 new positions and closed 16 in Q2 2019.
  • Elk Creek Partners's portfolio value fell 3.5% quarter-over-quarter to $1.34B.

Based on Elk Creek Partners's 13F filing for Q2 2019, filed 9 Aug 2019.